Six-Week Open-Label Reboxetine Treatment in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

This open-label study assessed the effectiveness of reboxetine, a selective norepinephrine reuptake inhibitor, in children and adolescents with attention-deficit/hyperactivity disorder (ADHD) resistant to a previous methylphenidate trial. Thirty-one child and adolescent outpatients, aged 8 to 18 (me...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American Academy of Child and Adolescent Psychiatry 2005-05, Vol.44 (5), p.428-433
Hauptverfasser:	Ratner, Sharon, Laor, Nathaniel, Bronstein, Yifat, Weizman, Abraham, Toren, Paz
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adolescents Adrenergic Uptake Inhibitors - administration & dosage Adrenergic Uptake Inhibitors - adverse effects Adrenergic Uptake Inhibitors - therapeutic use Adult and adolescent clinical studies Anxiety anxiety symptoms Attention Deficit and Disruptive Behavior Disorders - epidemiology Attention Deficit Disorder with Hyperactivity - diagnosis Attention Deficit Disorder with Hyperactivity - drug therapy Attention Deficit Disorder with Hyperactivity - epidemiology Attention Deficit Disorders Attention deficit hyperactivity disorder Biological and medical sciences Child Clinical trials Depression Depression (Psychology) depressive symptoms Diagnostic and Statistical Manual of Mental Disorders Double-Blind Method Drug therapy Effectiveness studies Female Humans Hyperactivity Inhibitor drugs Male Manifest Anxiety Scale Medical sciences Mental depression Mood disorders Morpholines - administration & dosage Morpholines - adverse effects Morpholines - therapeutic use Neuropharmacology Pediatrics Pharmacology. Drug treatments Program Effectiveness Psychiatry Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Psychopharmacology Rating Scales reboxetine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!